47 related articles for article (PubMed ID: 22095915)
1. ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum.
Zong S; Kron MW; Epp C; Engler T; Bujard H; Kochanek S; Kreppel F
J Gene Med; 2011 Dec; 13(12):670-9. PubMed ID: 22095915
[TBL] [Abstract][Full Text] [Related]
2. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
Kron MW; Engler T; Schmidt E; Schirmbeck R; Kochanek S; Kreppel F
J Gene Med; 2011 Dec; 13(12):648-57. PubMed ID: 22095925
[TBL] [Abstract][Full Text] [Related]
3. New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
Goodman AL; Epp C; Moss D; Holder AA; Wilson JM; Gao GP; Long CA; Remarque EJ; Thomas AW; Ammendola V; Colloca S; Dicks MD; Biswas S; Seibel D; van Duivenvoorde LM; Gilbert SC; Hill AV; Draper SJ
Infect Immun; 2010 Nov; 78(11):4601-12. PubMed ID: 20713623
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1.
Carralot JP; Lemmel C; Stevanovic S; Pascolo S
Int Immunol; 2008 Nov; 20(11):1451-6. PubMed ID: 18794202
[TBL] [Abstract][Full Text] [Related]
5. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
[TBL] [Abstract][Full Text] [Related]
6. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
[TBL] [Abstract][Full Text] [Related]
7. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
8. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
Rodríguez A; Mintardjo R; Tax D; Gillissen G; Custers J; Pau MG; Klap J; Santra S; Balachandran H; Letvin NL; Goudsmit J; Radosević K
Vaccine; 2009 Oct; 27(44):6226-33. PubMed ID: 19686691
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum 19 kDa of merozoite surface protein-1 (MSP-1(19)) expressed in Mycobacterium bovis bacille Calmette Guerin (BCG) is reactive with an inhibitory but not a blocking monoclonal antibody.
Nurul AA; Rapeah S; Norazmi MN
Trop Biomed; 2010 Apr; 27(1):60-7. PubMed ID: 20562815
[TBL] [Abstract][Full Text] [Related]
12. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.
Chang SP; Nikaido CM; Hashimoto AC; Hashiro CQ; Yokota BT; Hui GS
J Immunol; 1994 Apr; 152(7):3483-90. PubMed ID: 8144929
[TBL] [Abstract][Full Text] [Related]
13. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification and characterization of allelic variants of MSP-1(42) from Indian Plasmodium falciparum isolates.
Lalitha PV; Biswas S; Pillai CR; Seth RK; Saxena RK
Vaccine; 2010 Jun; 28(29):4661-7. PubMed ID: 20452429
[TBL] [Abstract][Full Text] [Related]
15. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
O'Donnell RA; Saul A; Cowman AF; Crabb BS
Nat Med; 2000 Jan; 6(1):91-5. PubMed ID: 10613831
[TBL] [Abstract][Full Text] [Related]
16. [Specific antibodies against Plasmodium falciparum antigens in immune subjects: II. Screening of responses against the merozoite major surface antigen (MSP!)].
Nguer CM; Diouf A; Diallo TO; Dieye A; Tall A; Diouf B; Molez JF; Trape JF; Perraut R; Garraud O
Dakar Med; 1997; 42(2):106-10. PubMed ID: 9827130
[TBL] [Abstract][Full Text] [Related]
17. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
[TBL] [Abstract][Full Text] [Related]
18. A PCR method for molecular epidemiology of Plasmodium falciparum Msp-1.
Tanabe K; Sakihama N; Kaneko O; Saito-Ito A; Kimura M
Tokai J Exp Clin Med; 1998 Dec; 23(6):375-81. PubMed ID: 10622635
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
[TBL] [Abstract][Full Text] [Related]
20. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
Lozano JM; Lesmes LP; Gallego GM; Patarroyo ME
Mol Immunol; 2011 Jan; 48(4):657-69. PubMed ID: 21131051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]